,

NDFS13 NINDS Presentation: Overview and Update on HHS SBIR/STTR Programs

Dr. Charles Cywin of the National Institute of Neurological Disorders and Stroke spoke about the programs available to support neuroscience translational research.

View Slide Deck

/by
You might also like
NDFS13 BARDA Presentation: Partnering with the Biomedical Advanced Research and Development Authority
Available Online: Non-Dilutive Funding Opportunities for Cancer R&D
Biomedical Advanced Research and Development Authority (BARDA) Presentation, at the 18th Non-Dilutive Funding Summit, by Director of Medical Countermeasures, Dr. Robert JohnsonBARDA at NDFS 2023, with Dr. Robert Johnson
SBIR/STTR Programs Could Expire September 30. Reauthorization Opposed by Rand Paul.SBIR/STTR Programs Could Expire Sept. 30
NDFS13 Company Presentation: Tangen Biosciences’ Successful Non-Dilutive Funding Journey
Come hear Dr. Kathleen Rousche, Director of the Innovation and Commercialization Office of the Nation Heart, Lung, and Blood Institute (NHLBI) at NIH, on Funding for R&D to Prevent, Diagnose, or Treat Heart, Lung, Blood, or Sleep Problems, at the 18th Annual Non-Dilutive Funding Summit, Wednesday, January 11, 2023, at the Marines' Memorial Club and Hotel, Union Square, San FranciscoNHLBI to Join NDFS 2023
The Advanced Research Projects Agency for Health (ARPA-H) Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Inaugural Director Dr. Renee WegrzynARPA-H at NDFS 2023, with Inaugural Director Dr. Renee Wegrzyn
Reviewing the NIH Review Criteria